Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Elevated Cardiac RiskCoronary Arteries Disease Risk
Interventions
DRUG

Xenon

DRUG

Sevoflurane

Trial Locations (13)

13915

CHU Nord, Marseille

21079

CHU Dijon, Dijon

33076

Hopital Pellegrin, Bordeaux

33604

CHU Bordeaux Haut Lévèque, Bordeaux

35009

CHU Rennes, Rennes

63003

CHU Clermont Ferrand, Clermont-Ferrand

67091

Nouvel Hopital Civil, Strasbourg

75013

Chu Pitie Salpetriere, Paris

75014

Hopital Saint Joseph, Paris

94000

Hopital Henri Mondor, Créteil

14033 Cedex 9

Centre Hospitalier Universitaire de Caen - Pôle Anesthésie-Réanimation-SAMU, Avenue de la Côte de Nacre, Caen

59037 Cedex

CHRU, Hôpital Cardiologique, Département Anesthésie-Réanimation, Bld du Président Jules Leclerc, Lille

86021 Cedex

CHU Poitiers, Service Anesthésie-Réanimation, 2 rue de Milétrie, BP577, Poitiers

Sponsors
All Listed Sponsors
collaborator

Eurofins Biomnis

OTHER

collaborator

Monitoring Force Group

INDUSTRY

collaborator

Inferential

INDUSTRY

lead

Air Liquide Santé International

INDUSTRY